title: Simeprevir-induced severe withdrawal syndrome in an HIV/HCV coinfected patient on long-term maintenance methadone therapy.
authors.affiliation: Department of Infectious Diseases, Luigi Sacco University Hospital, Via GB Grassi 74, 20157, Milan, Italy, cristina.gervasoni@unimi.it.
authors.forename: Cristina
authors.initials: C
authors.lastname: Gervasoni
authors.forename: Anna Maria
authors.initials: AM
authors.lastname: Peri
authors.forename: Dario
authors.initials: D
authors.lastname: Cattaneo
authors.forename: Sara
authors.initials: S
authors.lastname: Baldelli
authors.forename: Giuliano
authors.initials: G
authors.lastname: Rizzardini
authors.forename: Laura
authors.initials: L
authors.lastname: Milazzo
mesh_terms: D023241:Antiretroviral Therapy, Highly Active; D000998:Antiviral Agents / Q000009:adverse effects* / Q000627:therapeutic use; D060085:Coinfection / Q000188:drug therapy; D004347:Drug Interactions; D015658:HIV Infections / Q000188:drug therapy; D006526:Hepatitis C / Q000188:drug therapy; D006556:Heroin Dependence / Q000188:drug therapy; D006801:Humans; D008297:Male; D008691:Methadone / Q000009:adverse effects* / Q000627:therapeutic use; D008875:Middle Aged; D058850:Opiate Substitution Treatment / Q000009:adverse effects*; D012254:Ribavirin / Q000627:therapeutic use; D000069616:Simeprevir / Q000009:adverse effects* / Q000627:therapeutic use; D000069474:Sofosbuvir / Q000627:therapeutic use; D013375:Substance Withdrawal Syndrome / Q000209:etiology*
chemical_list: D000998:Antiviral Agents; D012254:Ribavirin; D000069616:Simeprevir; D008691:Methadone; D000069474:Sofosbuvir